Your browser doesn't support javascript.
loading
The fourth dose: My “me-first” experience
Indian J Med Ethics ; 2022 Sep; 7(3): 237-239
Article | IMSEAR | ID: sea-222678
ABSTRACT
Vaccine inequality is the biggest obstacle to curbing the Covid-19 pandemic and accelerating socio-economic recovery in the developing countries. Many people, including myself, living in developing countries, were initially inoculated with the WHO-approved vaccines unwelcome to developed countries, such as Sinovac. Presently, governments in developing countries are offering the third and fourth doses of mRNA vaccines to facilitate cross-border travel. This creates a devastating burden on ongoing Covid-19 vaccination in developing countries, increasing the injustice and inequality between the developed and developing countries. Here, I share my thoughts as a public health specialist while I was receiving the fourth dose of the Covid-19 vaccine to fulfil travel requirements.

Texte intégral: Disponible Indice: IMSEAR (Asie du Sud-Est) Texte intégral: Indian J Med Ethics Thème du journal: Ethics Année: 2022 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: IMSEAR (Asie du Sud-Est) Texte intégral: Indian J Med Ethics Thème du journal: Ethics Année: 2022 Type: Article